NEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the September 16th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.
This virtual event showcased live executive presentations and interactive discussions focused on publicly traded companies in the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”.
REGISTER OR LOGIN AT: https://bit.ly/3hFx0MB
September 16th Presenting Companies:
| Presenting Company | Ticker(s) |
| VolitionRx Limited | NYSE AMERICAN: VNRX |
| Avicanna Inc. | (OTCQX: AVCNF | TSX: AVCN) |
| Alpha Cognition Inc. | OTCQB: ACOGF | TSX-V: ACOG |
| Willow Biosciences Inc. | (OTCQX: CANSF | TSX: WLLW) |
| Filament Health Corp. | (Pink: FLHLF | NEO: FH) |
| Novamind Inc. | (OTCQB: NVMDF | CSE: NM) |
| Salarius Pharmaceuticals, Inc. | Nasdaq: SLRX |
| MedX Health Corp. | TSX-V: MDX |
| Wesana Health Holdings Inc. | (OTCQB: WSNAF | CSE: WESA) |
| Compass Therapeutics, Inc. | OTCQB: CMPX |
| Else Nutrition Holdings Inc. | (OTCQX: BABYF | TSX-V: BABY) |
To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com.
About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.
A real-time solution for investor engagement, Life Sciences Investor Forum is specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
CONTACT
Life Sciences Investor Forum
John M. Viglotti
SVP Corporate Services, Investor Access
(212) 220-2221
johnv@lifesciencesinvestorforum.com
